Get Premium to unlock powerful stock data

BioImpact Capital LLC Buys MEI Pharma Inc, Intellia Therapeutics Inc, BioCryst Pharmaceuticals Inc

Author's Avatar
insider
Nov 15, 2021
Article's Main Image
Investment company BioImpact Capital LLC (Current Portfolio) buys MEI Pharma Inc, Intellia Therapeutics Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc, Verastem Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, BioImpact Capital LLC. As of 2021Q3, BioImpact Capital LLC owns 33 stocks with a total value of $645 million. These are the details of the buys and sells.

For the details of BioImpact Capital LLC's stock buys and sells, go to https://www.gurufocus.com/guru/bioimpact+capital+llc/current-portfolio/portfolio

These are the top 5 holdings of BioImpact Capital LLC
  1. Cullinan Oncology Inc (CGEM) - 7,648,268 shares, 26.78% of the total portfolio. Shares reduced by 3.36%
  2. ITeos Therapeutics Inc (ITOS) - 2,107,092 shares, 8.82% of the total portfolio. Shares reduced by 9.9%
  3. Repare Therapeutics Inc (RPTX) - 1,639,849 shares, 6.67% of the total portfolio. Shares reduced by 2.16%
  4. Werewolf Therapeutics Inc (HOWL) - 2,388,011 shares, 6.36% of the total portfolio.
  5. MEI Pharma Inc (MEIP) - 12,494,118 shares, 5.35% of the total portfolio. New Position
New Purchase: MEI Pharma Inc (MEIP)

BioImpact Capital LLC initiated holding in MEI Pharma Inc. The purchase prices were between $2.52 and $2.99, with an estimated average price of $2.76. The stock is now traded at around $3.150000. The impact to a portfolio due to this purchase was 5.35%. The holding were 12,494,118 shares as of 2021-09-30.

New Purchase: Intellia Therapeutics Inc (NTLA)

BioImpact Capital LLC initiated holding in Intellia Therapeutics Inc. The purchase prices were between $132.37 and $176.78, with an estimated average price of $151.97. The stock is now traded at around $131.610000. The impact to a portfolio due to this purchase was 3.38%. The holding were 162,620 shares as of 2021-09-30.

New Purchase: BioCryst Pharmaceuticals Inc (BCRX)

BioImpact Capital LLC initiated holding in BioCryst Pharmaceuticals Inc. The purchase prices were between $14.21 and $17.65, with an estimated average price of $15.78. The stock is now traded at around $12.150000. The impact to a portfolio due to this purchase was 1.57%. The holding were 704,767 shares as of 2021-09-30.

New Purchase: Cytokinetics Inc (CYTK)

BioImpact Capital LLC initiated holding in Cytokinetics Inc. The purchase prices were between $18.54 and $35.74, with an estimated average price of $29.35. The stock is now traded at around $38.680000. The impact to a portfolio due to this purchase was 1.37%. The holding were 247,291 shares as of 2021-09-30.

New Purchase: Verastem Inc (VSTM)

BioImpact Capital LLC initiated holding in Verastem Inc. The purchase prices were between $2.54 and $4.07, with an estimated average price of $3.07. The stock is now traded at around $3.135000. The impact to a portfolio due to this purchase was 1.35%. The holding were 2,824,857 shares as of 2021-09-30.

New Purchase: Geron Corp (GERN)

BioImpact Capital LLC initiated holding in Geron Corp. The purchase prices were between $1.2 and $1.5, with an estimated average price of $1.34. The stock is now traded at around $1.535000. The impact to a portfolio due to this purchase was 1.22%. The holding were 5,732,770 shares as of 2021-09-30.

Added: Epizyme Inc (EPZM)

BioImpact Capital LLC added to a holding in Epizyme Inc by 70.40%. The purchase prices were between $4.82 and $8.46, with an estimated average price of $6.09. The stock is now traded at around $4.410000. The impact to a portfolio due to this purchase was 1.31%. The holding were 3,972,830 shares as of 2021-09-30.

Added: Merus NV (MRUS)

BioImpact Capital LLC added to a holding in Merus NV by 34.40%. The purchase prices were between $16.48 and $27.23, with an estimated average price of $21.52. The stock is now traded at around $29.350000. The impact to a portfolio due to this purchase was 0.82%. The holding were 941,948 shares as of 2021-09-30.

Added: ADC Therapeutics SA (ADCT)

BioImpact Capital LLC added to a holding in ADC Therapeutics SA by 58.02%. The purchase prices were between $20.45 and $30, with an estimated average price of $25.62. The stock is now traded at around $25.950000. The impact to a portfolio due to this purchase was 0.53%. The holding were 344,519 shares as of 2021-09-30.

Added: Y-mAbs Therapeutics Inc (YMAB)

BioImpact Capital LLC added to a holding in Y-mAbs Therapeutics Inc by 34.30%. The purchase prices were between $27.47 and $37.31, with an estimated average price of $31.57. The stock is now traded at around $22.145000. The impact to a portfolio due to this purchase was 0.51%. The holding were 452,970 shares as of 2021-09-30.



Here is the complete portfolio of BioImpact Capital LLC. Also check out:

1. BioImpact Capital LLC's Undervalued Stocks
2. BioImpact Capital LLC's Top Growth Companies, and
3. BioImpact Capital LLC's High Yield stocks
4. Stocks that BioImpact Capital LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus